A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

NCT02377466 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Asset terminated by PIB

Conditions

Obstetric Labour, Premature

Interventions

DRUG: Retosiban IV infusion
DRUG: Placebo IV infusion

Sponsor

GlaxoSmithKline

Collaborators

[object Object]